Log in
Enquire now
‌

US Patent 9657087 Subcutaneous administration of anti-hepatitis B antibodies

Patent 9657087 was granted and assigned to Omrix Biopharmaceuticals on May, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Omrix Biopharmaceuticals
Omrix Biopharmaceuticals
Current Assignee
Omrix Biopharmaceuticals
Omrix Biopharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9657087
Patent Inventor Names
Orgad Laub0
Nadav Orr0
Date of Patent
May 23, 2017
Patent Application Number
14306453
Date Filed
June 17, 2014
Patent Primary Examiner
‌
Agnieszka Boesen
Patent abstract

The present application relates to an immunoglobulin preparation comprising anti-hepatitis B antibodies for subcutaneous administration and to uses thereof, including methods for treating, preventing and/or reducing a disease, disorder or condition associated with hepatitis B virus.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9657087 Subcutaneous administration of anti-hepatitis B antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.